Silence Therapeutics plc (SLN)
NASDAQ: SLN · Real-Time Price · USD
6.19
-0.04 (-0.64%)
At close: Mar 9, 2026, 4:00 PM EDT
6.07
-0.12 (-1.94%)
After-hours: Mar 9, 2026, 6:33 PM EDT

Silence Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Market Capitalization
292287325672547715
Upgrade
Market Cap Growth
23.85%-11.59%-51.64%22.71%-23.44%17.04%
Upgrade
Enterprise Value
207185152600448612
Upgrade
Last Close Price
6.196.086.8817.3715.2523.89
Upgrade
PS Ratio
523.04513.747.5121.2325.2842.53
Upgrade
PB Ratio
4.694.612.4230.5420.5861.93
Upgrade
P/TBV Ratio
5.695.592.6157.6633.06580.25
Upgrade
P/FCF Ratio
-----96.09
Upgrade
P/OCF Ratio
-----77.58
Upgrade
EV/Sales Ratio
371.06331.263.5218.9720.6736.40
Upgrade
EV/FCF Ratio
-----82.24
Upgrade
Debt / Equity Ratio
0.000.000.000.020.020.02
Upgrade
Debt / FCF Ratio
-----0.03
Upgrade
Net Debt / Equity Ratio
-1.36-1.36-1.10-3.11-3.20-8.61
Upgrade
Net Debt / EBITDA Ratio
1.041.043.011.321.681.61
Upgrade
Net Debt / FCF Ratio
1.361.362.171.381.49-13.36
Upgrade
Asset Turnover
0.000.000.270.250.180.14
Upgrade
Quick Ratio
8.068.0610.364.154.035.41
Upgrade
Current Ratio
8.728.7211.144.624.415.69
Upgrade
Return on Equity (ROE)
-90.27%-90.27%-58.08%-223.22%-273.06%-448.22%
Upgrade
Return on Assets (ROA)
-30.79%-30.79%-19.24%-26.32%-26.09%-31.44%
Upgrade
Return on Capital Employed (ROCE)
-69.80%-69.80%-26.70%-54.00%-49.70%-56.50%
Upgrade
Earnings Yield
-30.31%-30.86%-13.95%-8.07%-9.20%-7.46%
Upgrade
FCF Yield
-21.32%-21.70%-20.89%-7.37%-10.45%1.04%
Upgrade
Buyback Yield / Dilution
-2.12%-2.12%-24.69%-15.21%-8.58%-8.78%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.